# T-cell Receptor α/β Depleted Donor Lymphocyte Infusion

> **NCT05350163** · PHASE1 · TERMINATED · sponsor: **Guenther Koehne** · enrollment: 11 (actual)

## Conditions studied

- Lymphoid Leukemia, Acute
- Myeloid Malignancy
- Plasma Cell Tumor

## Interventions

- **BIOLOGICAL:** T-cell Receptor α/β Depleted Donor Lymphocyte Infusions

## Key facts

- **NCT ID:** NCT05350163
- **Lead sponsor:** Guenther Koehne
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-04-05
- **Primary completion:** 2023-09-18
- **Final completion:** 2023-09-18
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** The study met criteria for stopping due to lack of efficacy per protocol specifications.
- **Last updated:** 2024-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05350163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05350163, "T-cell Receptor α/β Depleted Donor Lymphocyte Infusion". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05350163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*